CYCLOPHOSPHAMIDE
| Brand name | FRINDOVYX |
|---|---|
| Active ingredient | CYCLOPHOSPHAMIDE |
| Strength | 1GM/2ML (500MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | June 2023 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11382923 | December 2035 | product |
| 10849916 | July 2035 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.